Providers/Grant Support
This activity is supported by an educational grant from Lilly.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
- Nurses — 0.5 Nursing Contact Hours
- Physician Assistants — 0.5 AAPA Category 1 CME credits
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of dementia specialists, neurologists, geriatricians, geriatric psychiatrists, primary care providers, imaging physicians, advanced practice providers (NPs/PAs), but is relevant to all members of the multidisciplinary team that manage patients with Alzheimer’s disease.
Program Overview
This simulation-based module, led by Dr Chuck Vega and featuring his mother, Pat Vega, brings shared decision-making (SDM) to life in the context of biomarker use in Alzheimer’s disease (AD). Drawing from their family’s experience, they demonstrate the importance and key principles of SDM. Throughout the realistic clinical case, learners will navigate key decision points, including choices around biomarker use, communication strategies, and care planning for patients and their care partners.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Establish an SDM approach that prioritizes empathetic and clear communication with patients and caregivers throughout the biomarker testing process
Faculty
Dr. Chuck Vega
Clinical Professor of Family Medicine
UC Irvine, United States
Mrs. Pat Vega
Care partner
United States
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Springer Health+ IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.
Continuing Physician Assistant Education
The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 9/21/2026. PAs should only claim credit commensurate with the extent of their participation.
Disclosures of Conflict of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Dr Chuck Vega
Consultant/Advisory Board: Boehringer Ingelheim, Exact Sciences
Mrs Pat Vega
Nothing to disclose.
The PIM planners and others have nothing to disclose. The Springer Health+ IME planners and others have nothing to disclose.
All relevant financial relationships have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For CME questions please contact: [email protected]